miR-107 Targets NSG1 to Regulate Hypopharyngeal Squamous Cell Carcinoma Progression through ERK Pathway
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25115961 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yifan Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Cell Movement, Cell Proliferation, Gene Expression Regulation, Neoplastic, Hypopharyngeal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Central Universities, Zhongnan Hospital of Wuhan University Excellent Doctor (Postdoctoral) Fund, Hubei Provincial Natural Science Foundation.
Abstract (Originalsprache)
Hypopharyngeal squamous cell carcinoma (HSCC) is a kind of malignant tumor with a poor prognosis and low quality of life in the otolaryngology department. It has been found that microRNA (miRNA) plays an important role in the occurrence and development of various tumors. This study found that the expression level of miRNA-107 (miR-107) in HSCC was significantly reduced. Subsequently, we screened out the downstream direct target gene Neuronal Vesicle Trafficking Associated 1 (NSG1) related to miR-107 through bioinformatics analysis and found that the expression of NSG1 was increased in HSCC tissues. Following the overexpression of miR-107 in HSCC cells, it was observed that miR-107 directly suppressed NSG1 expression, leading to increased apoptosis, decreased proliferation, and reduced invasion capabilities of HSCC cells. Subsequent experiments involving the overexpression and knockdown of NSG1 in HSCC cells demonstrated that elevated NSG1 levels enhanced cell proliferation, migration, and invasion, while the opposite effect was observed upon NSG1 knockdown. Further investigations revealed that changes in NSG1 levels in the HSCC cells were accompanied by alterations in ERK signaling pathway proteins, suggesting a potential regulatory role of NSG1 in HSCC cell proliferation, migration, and invasion through the ERK pathway. These findings highlight the significance of miR-107 and NSG1 in hypopharyngeal cancer metastasis, offering promising targets for therapeutic interventions and prognostic evaluations for HSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
- Sleep Medicine Centre, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Förderung
- Central Universities
- Zhongnan Hospital of Wuhan University Excellent Doctor (Postdoctoral) Fund
- Hubei Provincial Natural Science Foundation
- Science, Technology and Innovation Seed Fund of Zhongnan Hospital of Wuhan University
- Zhongnan Hospital of Wuhan University
- Science, Technology, and Innovation Seed Fund of Zhongnan Hospital of Wuhan University
Zitieren
APA
Hu, Y., He, Z., Han, B., Lin, Z., Zhou, P., Li, S., Huang, S., & Chen, X. (2024). miR-107 Targets NSG1 to Regulate Hypopharyngeal Squamous Cell Carcinoma Progression through ERK Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115961
Vancouver
Hu Y, He Z, Han B, Lin Z, Zhou P, Li S, et al. miR-107 Targets NSG1 to Regulate Hypopharyngeal Squamous Cell Carcinoma Progression through ERK Pathway. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115961
BibTeX
@article{Hu2024,
author = {Hu, Yifan and He, Zhizhen and Han, Baoai and Lin, Zehua and Zhou, Peng and Li, Shuang and Huang, Shuo and Chen, Xiong},
title = {miR-107 Targets NSG1 to Regulate Hypopharyngeal Squamous Cell Carcinoma Progression through ERK Pathway},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25115961}
}
EUVIMED